Inventor
Paul J. Hergenrother
Inventor
Champaign, IL, US
Overview
Patents· 42 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds20%
C07CAcyclic or carbocyclic compounds4%
C07BGeneral methods of organic chemistry4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07HSugars3%
C07JSteroids2%
C07KPeptides2%
C09KMaterials for miscellaneous applications, not provided for elsewhere2%
PatentTitleYear
11,129,830PAC-1 combination therapy202111,046,647Activators of the unfolded protein response202110,995,097Small molecules active against gram-negative bacteria202110,918,735Substituted pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment202110,888,560Procaspase 3 activation by combination therapy202110,874,666Procaspase combination therapy for glioblastoma202010,800,730Complex and structurally diverse compounds202010,576,096Tumor-selective combination therapy202010,525,056Procaspase-activating compounds and methods202010,350,207PAC-1 combination therapy201910,285,986Compounds and anti-tumor NQO1 substrates201910,272,099Tumor-selective combination therapy201910,220,099Substituted pyrazino[1',2':1 ,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment201910,166,229Compounds and methods for the treatment of cancer201910,085,977Procaspase 3 activation by combination therapy201810,085,978Procaspase combination therapy for glioblastoma201810,081,592Complex and structurally diverse compounds201810,022,371Procaspase-activating compounds and methods20189,962,383Compounds, compositions and methods of agelastatin alkaloids20189,925,180'Compounds and anti-tumor NQO1 substrates'20189,920,069'Compounds for treatment of fluoroquinolone-resistant bacteria'20189,682,060'Small molecules that induce intrinsic pathway apoptosis'20179,663,482'Substituted piperazinyl acetohydrazide procaspase-activating compounds'20179,643,960'Procaspase activating compounds'20179,611,266'Compounds and anti-tumor NQO1 substrates'20179,592,229'Potent anticancer activity via dual compound activation'20179,522,901'Compositions and methods including cell death inducers and procaspase activation'20169,434,736'Compounds, compositions and methods of agelastatin alkaloids'20169,421,202'Procaspase combination therapy for glioblastoma'20169,399,035'Procaspase 3 activation by combination therapy'20169,382,215'Therapeutic methods and agents for treating myotonic dystrophy'20169,353,150'Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment'20169,249,116'Enzyme-activating compounds and compositions'20169,233,960'Compounds and anti-tumor NQO1 substrates'20169,102,661'Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs'20158,916,705'Procaspase-activating compounds and compositions'20148,778,945'Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs'20148,754,084'Therapeutic methods and agents for treating myotonic dystrophy'20148,592,584'Compositions and methods including cell death inducers and procaspase activation'20137,709,465'Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers'20107,632,972'Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells'20096,824,987'Small molecule printing'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004Based in Medford, MA, US· patent location history
2009–2021Based in Champaign, IL, US· patent location history
2010–2021Patents assigned to UNIV ILLINOIS (39)· patent assignee history
2013–2018Patents assigned to HERGENROTHER PAUL J (5)· patent assignee history
2016–2021Patents assigned to VANQUISH ONCOLOGY INC (7)· patent assignee history
2016–2021Patents assigned to MASSACHUSETTS INST TECHNOLOGY (5)· patent assignee history
2017–2020Patents assigned to UNIV TEXAS (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV ILLINOIS | 39 | 2010–2021 |
| VANQUISH ONCOLOGY INC | 7 | 2016–2021 |
| HERGENROTHER PAUL Jself | 5 | 2013–2018 |
| MASSACHUSETTS INST TECHNOLOGY | 5 | 2016–2021 |
| UNIV TEXAS | 5 | 2017–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Champaign, Illinois, US | 41 | 2009–2021 |
| Medford, Massachusetts, US | 1 | 2004 |